Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 26 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAILButler, L.; Liapis, V.; Bouralexis, S.; Welldon, K.; Hay, S.; Thai, L.; Labrinidis, A.; Tilley, W.; Findlay, D.; Evdokiou, A.
2009Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancerZinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2005RANK expression in normal and malignant cells: a monoclonal antibody studyKostakis, P.; Atkins, G.; Vincent, C.; Farrugia, A.; Findlay, D.; Evdokiou, A.; Zannettino, A.; Annual Meeting of the American Society for Bone and Mineral Research (27th : 2005 : Nashville, Tennessee)
2002Zoledronate is anabolic for human osteoblast-like cellsAtkins, G.; Pan, B.; Findlay, D.; To, L.; Evdokiou, A.; Labrinidis, A.; Bouralexis, S.; Zannettino, A.; American Society for Bone and Mineral Research. Conference (24th : 2002 : San Antonio, Texas)
2002Evidence for the maturation-dependent expression of an osteoclastogenic phenotype in human osteoblasts.Atkins, G.; Zannettino, A.; Kostakis, P.; Pan, B.; Farrugia, A.; Evdokiou, A.; Findlay, D.; American Society for Bone and Mineral Research. Conference (24th : 2002 : San Antonio, Texas)
2005Synergistic induction of prostate cancer cell death by g-tocotrienol and lovastatin is mediated by direct geranylgeranyl pyrophosphate inhibition through a caspase-independent pathwayOdysseos, A.; Vraka, P.; Liapis, V.; Hay, S.; Evdokiou, A.
2001Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosisAtkins, G.; Evdokiou, A.; Bouralexis, S.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2001Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAILClayer, M.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Atkins, G.; Findlay, D.
2000Sustained activation of Erk1/2 MAPK and cell growth suppression by the insert-negative, but not the insert-positive isoform of the human calcitonin receptorRaggatt, L.; Evdokiou, A.; Findlay, D.
2000Expression of osteoclast differentiation signals by stromal elements of giant cell tumorsAtkins, G.; Haynes, D.; Graves, S.; Evdokiou, A.; Hay, S.; Bouralexis, S.; Findlay, D.